Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine

Clinical trial NCT05477693 · COMPLETED

Trial details

NCT number: NCT05477693
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pneumococcal Infections

Start date: 2022-10-25
Primary completion: 2023-04-10
Enrollment: 1800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.